Clarisis Organics
In the Dec 2025 quarter, revenue was under ₹1 Cr in both quarters and net profit was −₹0.15 Cr, against ₹1.43 Cr a year earlier (compared with Dec 2024). Promoters held 95.00% of Clarisis Organics in Dec 2025, unchanged from Sep 2025.
Peer Comparison
Commodities › Chemicals & Petrochemicals › Commodity Chemicals
| ₹2,348.10 | 32.20 | 69,604 Cr | 4.55 | 0.21% | 13.07% | 14.64% | 17,997 Cr | 2,162 Cr | |
| ₹603.55 | — | 15,376 Cr | 0.73 | 1.84% | -7.73% | -2.69% | 15,521 Cr | -1,971 Cr | |
| ₹1,178.10 | 15.11 | 14,872 Cr | 2.17 | 0.84% | 9.90% | 11.30% | 12,189 Cr | 984 Cr | |
| ₹514.70 | 7.29 | 7,563 Cr | 0.83 | 4.12% | 8.75% | 10.38% | 8,860 Cr | 1,037 Cr | |
| — | 103.79 | 7,489 Cr | 10.36 | 0.13% | 18.80% | 25.38% | 725 Cr | 68 Cr | |
| ₹552.10 | 61.07 | 4,055 Cr | 0.78 | 3.20% | -0.05% | 1.29% | 4,622 Cr | 66 Cr | |
| ₹386.75 | 7.70 | 3,563 Cr | 1.00 | 3.04% | 13.30% | 16.87% | 3,138 Cr | 473 Cr | |
Clarisis Organics (this company) | — | — | — | — | — | — | — | 76 Cr | 1 Cr |
| Median 8 companies | ₹577.83 | 23.66 | 7,563 Cr | 1.00 | 1.84% | 9.90% | 11.30% | 6,741 Cr | 271 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
2- Company has low interest coverage ratio.
- Company's cost of borrowing seems high
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75.5 | 0 | 0 | 0 |
| Expenses | 0.85 | 941 | 0.82 | 5.36 | 0.63 | 1.56 | 3.64 | -1.64 | 0.01 | 67.98 | 0.03 | 0.03 | 0.07 |
| Operating Profit | -0.85 | -941 | -0.82 | -5.36 | -0.63 | -1.56 | -3.64 | 1.64 | -0.01 | 7.52 | -0.03 | -0.03 | -0.07 |
| OPM % | — | — | — | — | — | — | — | — | — | 9.96% | — | — | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 28.24 | 20.08 | 9.48 | 14.14 | -43.6 | 13.99 | 14.14 | 14.16 |
| Interest | 0 | 0 | 0 | 0.63 | 1.51 | 26.63 | 14.21 | 10.17 | 12.66 | -37.03 | 13.46 | 14.05 | 14.21 |
| Depreciation | 0.11 | 0.11 | 0.05 | 0 | 0 | 0.09 | 0.04 | 0.04 | 0.04 | -0.13 | 0.02 | 0.02 | 0.02 |
| PBT | -0.96 | -941 | -0.87 | -5.99 | -2.14 | -0.04 | 2.19 | 0.91 | 1.43 | 1.08 | 0.48 | 0.04 | -0.14 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.96 | -941 | -0.88 | -5.99 | -2.14 | -0.04 | 2.18 | 0.91 | 1.43 | 1.08 | 0.47 | 0.04 | -0.15 |
| EPS (₹) | -0.37 | -365 | -0.34 | -5.99 | -2.14 | -0.04 | 2.18 | 0.91 | 1.43 | 1.08 | 0.47 | 0.04 | -0.15 |
Profit & Loss
| Particulars | Sep 2006 | Mar 2009 | Mar 2010 |
|---|---|---|---|
| Sales | 3.84 | -0.04 | -0.03 |
| Expenses | 4.57 | 0.38 | 0.42 |
| Operating Profit | -0.73 | -0.42 | -0.45 |
| OPM % | -19.01% | — | — |
| Other Income | 0.96 | 0.36 | 0.3 |
| Interest | 1.02 | 1.31 | 1.49 |
| Depreciation | 0.98 | 0.97 | 0.97 |
| PBT | -1.77 | -2.34 | -2.61 |
| Tax % | 0.56% | 0% | 0% |
| Net Profit | -1.78 | -2.34 | -2.61 |
| Div. Payout % | 0% | 0% | 0% |
Balance Sheet
| Particulars | Sep 2006 | Mar 2009 | Mar 2010 |
|---|---|---|---|
| Equity Capital | 10.35 | 10.35 | 10.35 |
| Reserves | -14.99 | -20.7 | -23.31 |
| Borrowings | 8.63 | 6.29 | 5.39 |
| Other Liabilities | 5.99 | 10.44 | 12.58 |
| Total Liabilities | 9.98 | 6.38 | 5.01 |
| Fixed Assets | 7.36 | 5 | 4.03 |
| CWIP | 0.08 | 0 | 0 |
| Investments | 0 | 0.01 | 0 |
| Other Assets | 2.54 | 1.37 | 0.98 |
| Total Assets | 9.98 | 6.38 | 5.01 |
Cash Flow
| Particulars | Sep 2006 | Mar 2009 | Mar 2010 |
|---|---|---|---|
| Operating | 1.5 | — | — |
| Investing | -0.11 | — | — |
| Financing | -1.97 | — | — |
| Net Cash Flow | -0.58 | — | — |
| Free Cash Flow | 1.39 | — | — |
| CFO/OP | -205 | — | — |
Ratios
| Particulars | Sep 2006 | Mar 2009 | Mar 2010 |
|---|---|---|---|
| Debtor Days | 144 | — | — |
| Inventory Days | 44.12 | — | — |
| Days Payable | 461 | — | — |
| Cash Conversion Cycle | -273 | — | — |
| Working Capital Days | -332 | — | — |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Clarisis Organics insights
24 extracted metrics + investor summaries across FY09–FY26.
Documents
Frequently Asked Questions about Clarisis Organics
Where is Clarisis Organics Ltd (524806) listed?
Which sector does Clarisis Organics Ltd belong to?
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524806.md for Clarisis Organics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.